Immuno-Oncology Frontiers / Berlin 2017

Immuno-Oncology has established itself in recent years as one of the most exciting therapeutic areas and has experienced tremendous growth within funding and clinical trials alike. It is predicted that immunotherapies will eventually be used in as many as 60% of cases of advanced cancer. Discover the hottest new technologies and meet the latest cutting edge biotechs at Immuno-Oncology Frontiers, where you will find the perfect combination of strategic vision and emerging science. For sponsorship enquiries visit: http://www.cgteurope.com/forms/sponsorship-enquiry